Purpose: To develop a decision-making pathway for primary SA-LLIF. Furthermore, we analyzed the agreement of this pathway and compared outcomes of patients undergoing either SA-LLIF or 360-LLIF.

Method: A decision-making pathway for SA-LLIF was created based on the results of interviews/surveys of senior spine surgeons with over 10 years of experience. Internal validity was retrospectively evaluated using consecutive patients undergoing either SA-LLIF or 360-LLIF between 01/2018 and 07/2020 with 3D-printed Titanium cages. An outcome assessment looking primarily at revision surgery and secondary at cage subsidence, changes in disk and foraminal height, global and segmental lumbar lordosis, duration of surgery, estimated blood loss, and length of stay was carried out.

Results: 78 patients with 124 treated levels (37 SA-LLIF, 41 360-LLIF) were retrospectively analyzed. The pathway showed a direct agreement (SA-LLIF) of 100.0% and an indirect agreement (360-LLIF) of 95.1%. Clinical follow-up averaged 13.5 ± 6.5 months including 4 revision surgeries in the 360-LLIF group and none in the SA-LLIF group (p = 0.117). Radiographic follow-up averaged 9.5 ± 4.3 months, with no statistically significant difference in cage subsidence rate between the groups (p = 0.440). Compared to preoperative images, patients in both groups showed statistically significant changes in disk height (p < 0.001), foraminal height (p < 0.001), as well as restoration of segmental lordosis (p < 0.001 and p = 0.018). The SA-LLIF group showed shorter duration of surgery, less estimated blood loss and shorter LOS (p < 0.001).

Conclusion: The proposed decision-making pathway provides a guide to adequately select patients for SA-LLIF. Further studies are needed to assess the external applicability and validity.

Level Of Evidence Iii: Diagnostic: individual cross-sectional studies with consistently applied reference standard and blinding.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00586-021-07027-4DOI Listing

Publication Analysis

Top Keywords

decision-making pathway
12
patients undergoing
8
undergoing sa-llif
8
sa-llif 360-llif
8
cage subsidence
8
changes disk
8
follow-up averaged
8
sa-llif
7
pathway
5
development decision-making
4

Similar Publications

The unpredictability of the epidemics caused by new, unknown viruses, combined with differing responsibilities among government departments, often leads to a prisoner's dilemma in epidemic information governance. In this context, the whistle-blower effect in the health departments leads to delayed reporting to avoid potential retaliation, and the cry-wolf effect in the administrative departments results in sustained observation to avoid ineffective warnings. To address these challenges, we employ game theory to analyze the dynamics of epidemic information governance and focus on two external governance mechanisms-superior accountability and media supervision-that can help resolve the prisoner's dilemma during and after an outbreak.

View Article and Find Full Text PDF

Piloting of a Decision Aid for Recurrent Tonsillitis.

Clin Otolaryngol

January 2025

Clinical Psychology Department, NHS Grampian, Aberdeen Royal Infirmary, Aberdeen, Scotland, UK.

Objective: Currently, there is no adult-specific decision aid (DA) to support decision-making regarding recurrent tonsillitis. This study intends to address this gap by piloting a prototype DA.

Design: Randomised clinical trial.

View Article and Find Full Text PDF

Treatment options to break the cycle of recurrent pericarditis.

Curr Opin Cardiol

January 2025

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Purpose Of Review: This review provides a contemporary, evidence-based update on the pathophysiological mechanisms and rapidly evolving therapeutic options for recurrent pericarditis.

Recent Findings: Recent studies have elucidated the pathogenesis of recurrent pericarditis, identifying autoinflammation as a key mechanism and interleukin-1 (IL-1) as a central modulator of the inflammatory cascade. Multiple clinical trials have investigated novel therapeutic approaches, particularly focusing on IL-1 inhibition.

View Article and Find Full Text PDF

Background: Sturge-Weber Syndrome (SWS) is a rare, sporadic neurocutaneous disorder affecting the skin, brain, and eyes, due to somatic activating mutations in GNAQ or, less commonly, GNA11 gene. It is characterized by at least two of the following features: a facial capillary malformation, leptomeningeal vascular malformation, and ocular involvement. The spectrum of clinical manifestations includes headache, seizures, stroke-like events, intellectual disability, glaucoma, facial asymmetry, gingival hyperplasia, etc.

View Article and Find Full Text PDF

The personalized information service My Cancer Navigator (MCN) answers therapy-related questions of patients with cancer and their caregivers, to address information needs and contribute to shared decision-making (SDM). An explorative and descriptive cross-sectional study using online surveys was conducted to assess whether users perceived a change in factors contributing to SDM after using the service. Of 253 invited MCN users, 109 (43.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!